North China Pharmaceutical Company.Ltd (SHA:600812)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Anti-infective	4.98B
Anti-infective Growth	0.73%
Epidemic Prevention	1.32B
Epidemic Prevention Growth	-0.63%
Pesticides and Veterinary Drugs	765.35M
Pesticides and Veterinary Drugs Growth	9.64%
Pharmaceutical Intermediates	615.04M
Pharmaceutical Intermediates Growth	-14.44%
Nephropathy and Immune Regulation	464.33M
Nephropathy and Immune Regulation Growth	6.50%
Pharmaceutical and Other Logistics Trade	455.31M
Pharmaceutical and Other Logistics Trade Growth	-41.01%
Cardiovascular and Cerebrovascular	285.57M
Cardiovascular and Cerebrovascular Growth	21.18%
Nervous and Blood System Drugs	264.31M
Nervous and Blood System Drugs Growth	46.88%
Vitamins and Health Consumer Products	236.29M
Vitamins and Health Consumer Products Growth	1.31%
Other	484.75M
Other Growth	-15.83%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
China	7.95B
China Growth	-7.92%
Abroad	1.84B
Abroad Growth	28.79%